Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arteris, Inc.AIP · Entity 2399 | Director · President and CEO · 10% owner | October 05, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arteris, Inc.
Report date October 05, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 154,337 |
Reported balance
After 2026-10-05 transaction · row 1
1 source rowRow 1 · 2026-10-05 · Sale · Disposed 11,452 · Balance 154,337 F1: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on December 12, 2025. F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.89 to $24.49 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | IndirectBayview Legacy, LLC | 8,129,071 |
Reported balance
Holding disclosure · report date 2026-10-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 8,129,071 F3: The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC. |
| Common StockSEC Table I · non-derivative | IndirectCharles and Lydia Janac Trust | 56,252 |
Reported balance
Holding disclosure · report date 2026-10-05 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 56,252 F4: The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on December 12, 2025.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.89 to $24.49 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC.
F4: The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2022 Filed Dec 5, 2022 22:36 UTC | Arteris, Inc. AIP · Entity 2399 | GiftCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-021294 · doc1.xml · nonDerivative · entry 1 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 10,323,891 F1 · ownership.nature: The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy LLC. Read SEC document |
| May 17, 2022 Filed May 19, 2022 22:55 UTC | Arteris, Inc. AIP · Entity 2399 | SaleCommon Stock | 2,000 | $8.08 | $16,166.60 |
DisclosureSEC source: 0001567619-22-011313 · doc1.xml · nonDerivative · entry 1 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,564 F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $7.85 to $8.35 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy LLC. Read SEC document |
| May 02, 2022 Filed May 5, 2022 01:21 UTC | Arteris, Inc. AIP · Entity 2399 | Tax withholdingCommon Stock | 2,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-009542 · form4.xml · nonDerivative · entry 1 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,564 F1 · balance_after: Includes 50,564 restricted stock units. Read SEC document |
| November 11, 2021 Filed Nov 19, 2021 23:59 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 52,971 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-020901 · doc1.xml · nonDerivative · entry 1 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,971 F1 · shares: Includes 52,971 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 12.5% of the total RSUs on 5/1/2022 and in equal quarterly installments thereafter. The RSUs have no expiration date. F2 · balance_after: Includes 52,971 restricted stock units. Read SEC document |
| November 11, 2021 Filed Jan 14, 2022 23:02 UTC Amendment | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 52,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-001216 · doc1.xml · nonDerivative · entry 1 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,849 F1 · shares: The original form 4 inadvertently overstated the number of restricted stock units ("RSUs") awarded. This amendment is being filed to correctly report the number of RSUs earned and the total number of shares beneficially owned following the reported transaction. Reflects 52,849 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 12.5% of the total RSUs on 5/1/2022 and in equal quarterly installments thereafter. The RSUs have no expiration date. F2 · balance_after: Includes 52,849 restricted stock units. Read SEC document |
| October 29, 2021 Filed Nov 19, 2021 23:53 UTC | Arteris, Inc. AIP · Entity 2399 | ConversionSeries A Preferred Stock · Derivative | 335,891 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-020897 · doc1.xml · derivative · entry 5 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Arteris IP, LLC Disclosed balance after: 335,891 Underlying: Common Stock · 335,891 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · ownership.nature: The Reporting Person is the manager of Arteris IP, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Arteris IP, LLC. Read SEC document |
| October 29, 2021 Filed Nov 19, 2021 23:53 UTC | Arteris, Inc. AIP · Entity 2399 | ConversionSeries A Preferred Stock · Derivative | 77,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-020897 · doc1.xml · derivative · entry 4 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Janac Trust Disclosed balance after: 77,286 Underlying: Common Stock · 77,286 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| October 29, 2021 Filed Nov 19, 2021 23:53 UTC | Arteris, Inc. AIP · Entity 2399 | ConversionCommon Stock | 335,891 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-21-020897 · doc1.xml · nonDerivative · entry 2 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Arteris IP, LLC Disclosed balance after: 10,335,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · ownership.nature: The Reporting Person is the manager of Arteris IP, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Arteris IP, LLC. Read SEC document |
| October 29, 2021 Filed Nov 19, 2021 23:53 UTC | Arteris, Inc. AIP · Entity 2399 | ConversionCommon Stock | 77,286 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-21-020897 · doc1.xml · nonDerivative · entry 1 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Janac Trust Disclosed balance after: 77,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.